Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Bulletin Du Cancer|January 1, 1988
[Clinical pharmacokinetics of nitrosoureas]J P Bizzari, P DeloffreBone|August 16, 2003
S12911-2 reduces bone loss induced by short-term immobilization in ratsM Hott, P Deloffre, Y Tsouderos, et al.European Journal of Drug Metabolism and Pharmacokinetics|March 15, 2000
Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulationsJ P Devissaguet, N Brion, O Lhote, et al.Intensive Care Medicine|May 6, 1999
Influence of alveolar ventilation changes on calculated gastric intramucosal pH and gastric-arterial PCO2 differenceG Bernardin, P Lucas, H Hyvernat, et al.Intensive Care Medicine|January 1, 1996
Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shockG Bernardin, C Pradier, F Tiger, et al.Bulletin Du Cancer|January 1, 1989
[Study of the clinical pharmacokinetics of fotemustine in various tumor indications]F Lokiec, K Beerblock, P Deloffre, et al.Bone|June 1, 1996
The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitroE Canalis, M Hott, P Deloffre, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 1, 1991
Pharmacokinetic profile of fotemustine in rat plasma by electrochemical detectionI Bartosek, M Corada, S Dallarda, et al.Bone|October 1, 1995
Comparison between bone density and bone strength in glucocorticoid-treated aged ewesP Deloffre, D Hans, C Rumelhart, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 1, 1993
An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient ratsP J Marie, M Hott, D Modrowski, et al.Pageof 2